Veterinary Medicines

Phenoxypen WSP

Authorised
  • Phenoxymethylpenicillin potassium
Download as PDF

Product identification

Medicine name:
Phenoxypen WSP
Phenoxylin 325 mg/g pulver til oral opløsning
Active substance:
  • Phenoxymethylpenicillin potassium
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Oral use

Product details

Active substance and strength:
  • Phenoxymethylpenicillin potassium
    325.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        2
        day
      • Eggs
        0
        day
  • Oral use
    • Chicken
      • Meat and offal
        2
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CE02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • White polypropylene bucket provided with a polypropylene lid containing 5 kg of product.
  • White polypropylene bucket provided with a polypropylene lid containing 2.5 kg of product.
  • Securitainer: white PP cylin drical container, with white HDPE/LDPE closure, with thumb tab for opening, containing 1000 g (1875 ml) of product.
  • Composite can: three layered rectangular container, which co nsists of a cardboard base with an inner lining of aluminium paper and with label on the outside containing 1 kg of product.
  • White polypropylene bucket provided with a polypropylene lid containing 1 kg of product.
  • Securitainer: white PP cylin drical container, with white HDPE/LDPE closure, with thumb tab for opening, containing 250 g (650 ml) of product.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 39520
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0121/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
Download